Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology. - Wikidata - wikimedia - TriplyDB

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

http://www.wikidata.org/entity/Q38105137

about

Convergence of nanotechnology and cancer prevention: are we there yet?Paper wasp nest-mediated biosynthesis of silver nanoparticles for antimicrobial, catalytic, anticoagulant, and thrombolytic applications Oxidative Damage and Energy Metabolism Disorder Contribute to the Hemolytic Effect of Amorphous Silica Nanoparticles.In vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers.Nanoparticles and the blood coagulation system. Part II: safety concerns.Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars.Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1H-NMR spectroscopy, a novel translational approach on a patient-specific basis.Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry.Controlled splitting and focusing of a stream of nanoparticles in a converging-diverging microchannel.New Avenues for Nanoparticle-Related Therapies.Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensions

P2860

Q28386699-D92BAFA5-5B4D-4287-96ED-084E74D70317 Q28829346-779B1DDF-0BB4-455C-BEB8-ADA90DC28A00 Q36526580-8492F1CE-27E6-4309-B5C4-9CD1A5E1E08D Q37202303-01B70E30-C93C-45F4-9078-B4DF6733E1E4 Q37612053-6E5DD4B2-8D3D-4248-8792-E1BCA95D467B Q38365804-61748121-68B1-469A-90B4-61541EA904C0 Q38495085-C3A8047A-52DD-49D2-B43C-2C8FDBE044E4 Q38632042-A91A2AFA-05E5-4F30-AD17-9DCD52B3E530 Q39121977-EDC60600-B917-42C7-AD22-C56D0558F3DC Q51510696-CB4A137B-6819-45D4-8E9E-362C30461880 Q55452723-9E4A3AA6-FF9E-4402-9E64-F0772D1CE434 Q58073502-355B16E6-268E-48AA-B9E8-984BA8B90E3D

P2860

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

http://www.wikidata.org/entity/Q38105137

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

@en

type

label

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

@en

prefLabel

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

@en

P1433

Q38105137-3CAE7C17-9092-4F7B-9CA9-89F39FA8CF33

P1476

Q38105137-ECB7BE1E-E3B0-44D6-92C9-33ECA7E056F6

P2093

Q38105137-101905C1-17E5-47E8-A6EE-5488B7403240

Q38105137-FFCED80F-DDF3-428E-8577-8FEC09057E79

P2860

Q38105137-03E7902D-4574-40AC-AEDE-2A71E211DDF8

Q38105137-08C4176D-FD49-43D8-BA7D-830D65E4E5B5

Q38105137-0A6DF309-A139-490E-B2B5-604FBA04DC7A

Q38105137-0B5D0CAB-A73A-4503-A415-2E854E06B292

Q38105137-0E9197D5-968F-4E9C-A972-0C84342DC83C

Q38105137-149C88CB-F72A-497A-9BDC-462F5AD86238

Q38105137-1C080CBB-AF45-49F7-940C-C9ABD0BBFB2E

Q38105137-219DFAB9-7BEC-43E5-8110-65A9609D2F12

Q38105137-26FA68F9-3AC2-4F03-AD4E-57CA4A87FC03

Q38105137-2A45F7FD-A816-4BC4-B6CC-41396A019D6E

P304

Q38105137-0738F4D4-6DDA-48E5-919D-4A91AD39D068

P31

Q38105137-E88A626D-C090-4BF3-ABEB-5BCFD2C0F9CB

P356

Q38105137-5B0F246A-29CB-4627-A590-4A684D638D45

P433

Q38105137-516D2B87-343D-4202-B133-EB381007BABD

P478

Q38105137-AF5801F5-B806-46AF-9D4A-99D813DA4045

P577

Q38105137-D8FB6DCA-355D-4395-B469-1F15B05937E1

P5875

Q38105137-5931F5CF-9202-41D1-B351-F7939D2AE1CE

P698

Q38105137-638659B5-A12F-48FE-8D03-F5A10BDD133E

P921

Q38105137-792859B2-12B1-4968-8349-2EF5733FE1AD

P356

P1433

P1476

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

@en

P2093

Anna N Ilinskaya

http://www.w3.org/2001/XMLSchema#string

Marina A Dobrovolskaia

http://www.w3.org/2001/XMLSchema#string

P2860

Second-generation perfluorocarbon emulsion blood substitutes

Emerging nanotechnology-based strategies for the identification of microbial pathogenesis

Immunological properties of engineered nanomaterials

Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.

Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.

Cancer, thrombosis and heparin-induced thrombocytopenia.

Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation.

Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries

PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors.

Nanoparticles and the immune system

P304

773-784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.13.48

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236664497

http://www.w3.org/2001/XMLSchema#string

P698

23656264

http://www.w3.org/2001/XMLSchema#string

P921